KDM3A and hepatocellular carcinoma: Concordantly, subsequent experiments were performed in our study for exploration purpose by delivering miR-202-3p mimic or siRNA targeting KDM3A, leading to suppressed proliferation, migration, and invasion capabilities of HCC cells in vitro as well as weakened tumorigenicity in vivo.